BlueRock Therapeutics Claimed Company
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
read more
BE THE FIRST TO ANSWER
How hard is it to get promoted at BlueRock Therapeutics?
0 Answers from Employees at BlueRock Therapeutics
About Company Q&A on Comparably
Help answer questions real people are asking about your company. Your answers will be 100% anonymous.
The person asking the question will be notified of your answer, and it will be posted publicly. Your identity will be kept private
Recently Asked Questions
No Questions Available
Recently Answered Questions
No Questions Available
×